Treatment for Hormonal Fluctuations Causing Dizziness and Heart Palpitations
Beta-blockers such as metoprolol are the first-line treatment for hormonal fluctuation-related dizziness and heart palpitations, particularly when symptoms are moderate to severe. 1, 2
Diagnostic Approach
When evaluating hormonal fluctuations causing dizziness and palpitations, consider:
- Laboratory testing: Complete blood count, electrolytes, glucose, and thyroid function tests 1
- Cardiovascular assessment: 12-lead ECG to assess for arrhythmias 1
- Timing of symptoms: Relationship to menstrual cycle, pregnancy, or perimenopausal status 3
Treatment Algorithm Based on Severity
Mild Symptoms
- Lifestyle modifications:
- Avoid triggers (caffeine, alcohol, nicotine)
- Adequate hydration
- Regular meals to maintain stable blood glucose
- Avoid excessive heat exposure 1
- Paracetamol (acetaminophen) for symptomatic relief 1
Moderate to Severe Symptoms
Beta-blockers:
Hormone therapy considerations:
Treatment of underlying endocrinopathies:
Special Considerations
Pregnancy
- Beta-1 selective blockers (metoprolol) may be used with caution for arrhythmia-related dizziness 1
- Manual therapy of cervical and thoracic spine may be considered 1
- Avoid activities with risk of falling 1
Perimenopause
- Symptoms are usually benign and related to increased sympathetic activity 3, 4
- Beta-blockers can effectively manage palpitations and associated dizziness 1, 2
Red Flags Requiring Immediate Attention
- Severe symptoms with hemodynamic instability
- Dizziness with neurological symptoms
- Persistent symptoms despite treatment
- Dizziness with significant cardiac symptoms 1
Monitoring and Follow-up
- Patients with moderate symptoms should have follow-up within 1-2 weeks 1
- ECG monitoring may be necessary if symptoms persist despite treatment 6
- Consider ambulatory ECG monitoring (Holter or event monitor) for patients with frequent but unpredictable episodes 6
Pitfalls to Avoid
- Don't attribute all symptoms to hormonal fluctuations without ruling out structural heart disease or arrhythmias 5, 6
- Avoid prescribing class I or III antiarrhythmic drugs without documented arrhythmia due to proarrhythmic risk 5
- Don't overlook thyroid dysfunction, which can cause both palpitations and dizziness 5
- Remember that palpitations may be perceived differently by each patient and may not correlate with actual arrhythmias 6
Beta-blockers remain the cornerstone of treatment for these symptoms, providing relief by reducing sympathetic tone and controlling heart rate, which addresses both the palpitations and associated dizziness.